Credit: Getty Images. A point-of-care polymerase chain reaction test has high sensitivity and specificity for Chlamydia trachomatis. HealthDay News — A point-of-care (POC) polymerase chain reaction ...

Chlamydia trachomatis is one of the most common sexually transmitted infections (STIs). Chlamydia can lead to serious complications if untreated. It can be hard to know if you have chlamydia since it ...

Experts say patients can get results before they leave the doctor’s office, allowing them to start treatments earlier. Share on Pinterest Researchers say the new chlamydia test is just as accurate as ...

Please provide your email address to receive an email when new articles are posted on . Compared with urine samples, vaginal swabs had significantly greater sensitivity for chlamydia and gonorrhea.

At-home STD tests offer convenience and privacy while testing for sexually transmitted diseases (STDs). These diseases are also called sexually transmitted infections (STIs). If you're sexually active ...

Up until now, people concerned that they might have chlamydia or gonorrhea would have to get tested at a doctor’s office. Users of the new test won’t need a prescription and can activate it online.

A potential solution to this problem is the use of point-of-care tests that can provide an immediate result, thereby allowing clinical services to offer treatment and begin the process of partner ...

Chlamydia often has no noticeable symptoms. If symptoms do appear, they usually do so between 7–21 days after exposure. Tests can usually detect chlamydia 1–2 weeks after exposure. The time between a ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to ...

When, a handful of years ago, the U.S. and Canada changed their screening guidelines for cervical cancer, it was an acknowledgment that screenings for young women carried unintended harms. However, a ...

Background and Objectives: More information is needed on the natural history of Chlamydia trachomatis urethral infections in men. Newer assays for detecting antigens in male first void urine and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new Aptima ® BV and Aptima ® CV/TV assays, which provide an accurate and ...